Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Advancing in shared decision making: asymptomatic carotid stenosis PMID: NOPMID0069 Journal: ANGIOLOGY Year: 2019 Reference: Advancing in shared decision making: asymptomatic carotid stenosis. Angiología. 2019;71(5):190-3. doi: 10.20960/angiologia.00052 Impact factor: 2.376 Publication type: Paper in national publication Authors: Morata Barrado, Pilar Caridad, Al-Raies Bolanos, Bader, Blanco Canibano, Estrella, Lopez Espada, Cristina, Barreiro Veiguela, Javier, Bellmunt Montoya, Sergi, Gil Sales, Jose, Florit Lopez, Salvador et al. DOI: 10.20960/angiologia.00052 Advancing in shared decision making: asymptomatic carotid stenosis PMID: NOPMID0069 Journal: ANGIOLOGY Year: 2019 Reference: Advancing in shared decision making: asymptomatic carotid stenosis. Angiología. 2019;71(5):190-3. doi: 10.20960/angiologia.00052 Impact factor: Publication type: Paper in national publication Authors: Al-Raies Bolanos, Bader; Barreiro Veiguela, Javier; Bellmunt Montoya, Sergi; Blanco Canibano, Estrella; Florit Lopez, Salvador; Gil Sales, Jose; Lopez Espada, Cristina; Morata Barrado, Pilar Caridad et al. DOI: 10.20960/angiologia.00052 Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. PMID: 30624662 Journal: ANNALS OF ONCOLOGY Year: 2019 Reference: Ann Oncol. 2019 Jul 1;30(7):1179. doi: 10.1093/annonc/mdy535. Impact factor: 14.196 Publication type: Letter or abstract Authors: Cortes, J, Calvo, V, Ramirez-Merino, N, O'Shaughnessy, J, Brufsky, A, Robert, N, Vidal, M, Munoz, E, Perez, J, Dawood, S et al. DOI: 10.1093/annonc/mdy535 Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. PMID: 30624662 Journal: ANNALS OF ONCOLOGY Year: 2019 Reference: Ann Oncol. 2019 Jul 1;30(7):1179. doi: 10.1093/annonc/mdy535. Impact factor: Publication type: Letter or abstract Authors: Baselga, J; Bellet, M; Brufsky, A; Calvo, V; Cortes, J; Dawood, S; Di Cosimo, S; Gonzalez-Martin, A; Llombart, A; Miles, D et al. DOI: 10.1093/annonc/mdy535 Afatinib in non-small cell lung cancer with HER2 mutations: results of the prospective, open-label phase II NICHE trial of European Thoracic Oncology Platform (ETOP). PMID: 30825613 Journal: Journal of Thoracic Oncology Year: 2019 Reference: J Thorac Oncol. 2019 Jun;14(6):1086-1094. doi: 10.1016/j.jtho.2019.02.017. Epub 2019 Feb 27. Impact factor: 12.46 Publication type: Paper in international publication Authors: Rabaglio, Manuela, Dziadziuszko, Rafal, Smit, Egbert F, Dafni, Urania, Wolf, Juergen, Wasag, Bartosz, Biernat, Wojciech, Finn, Stephen P, Kammler, Roswitha, Tsourti, Zoi et al. DOI: 10.1016/j.jtho.2019.02.017 Afatinib in non-small cell lung cancer with HER2 mutations: results of the prospective, open-label phase II NICHE trial of European Thoracic Oncology Platform (ETOP). PMID: 30825613 Journal: Journal of Thoracic Oncology Year: 2019 Reference: J Thorac Oncol. 2019 Jun;14(6):1086-1094. doi: 10.1016/j.jtho.2019.02.017. Epub 2019 Feb 27. Impact factor: Publication type: Paper in international publication Authors: Biernat, Wojciech; Dafni, Urania; Dziadziuszko, Rafal; Felip, Enriqueta; Finn, Stephen P; Kammler, Roswitha; Peters, Solange; Rabaglio, Manuela; Roschitzki-Voser, Heidi; Ruepp, Barbara et al. DOI: 10.1016/j.jtho.2019.02.017 Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. PMID: 31194247 Journal: JAMA Oncology Year: 2019 Reference: JAMA Oncol. 2019 Jun 13. pii: 2735890. doi: 10.1001/jamaoncol.2019.1146. Impact factor: 22.416 Publication type: Paper in international publication Authors: Harrington, Kevin, de Souza Viana, Luciano, Romanov, Ilya, Vermorken, Jan, Bourhis, Jean, Tahara, Makoto, Martins Segalla, Jose Getulio, Psyrri, Amanda, Vasilevskaya, Irina, Nangia, Chaitali Singh et al. DOI: 10.1001/jamaoncol.2019.1146 Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. PMID: 31194247 Journal: JAMA Oncology Year: 2019 Reference: JAMA Oncol. 2019 Jun 13. pii: 2735890. doi: 10.1001/jamaoncol.2019.1146. Impact factor: Publication type: Paper in international publication Authors: Asarawala, Nirav; Bourhis, Jean; Burtness, Barbara; Chaves-Conde, Manuel; Cohen, Ezra E W; de Souza Viana, Luciano; Del Campo, Josep Maria; Dinis, Jose; Ehrnrooth, Eva; Even, Caroline et al. DOI: 10.1001/jamaoncol.2019.1146 Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol. PMID: 30808583 Journal: Clinical Lung Cancer Year: 2019 Reference: Clin Lung Cancer. 2019 May;20(3):e407-e412. doi: 10.1016/j.cllc.2018.12.022. Epub 2019 Jan 4. Impact factor: 4.117 Publication type: Paper in international publication Authors: Levy, Benjamin, Paz-Ares, Luis, Bennouna, Jaafar, Felip, Enriqueta, Abreu, Delvys Rodriguez, Isla, Dolores, Barlesi, Fabrice, Molinier, Olivier, Madelaine, Jeannick, Audigier-Valette, Clarisse et al. DOI: 10.1016/j.cllc.2018.12.022 Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol. PMID: 30808583 Journal: Clinical Lung Cancer Year: 2019 Reference: Clin Lung Cancer. 2019 May;20(3):e407-e412. doi: 10.1016/j.cllc.2018.12.022. Epub 2019 Jan 4. Impact factor: Publication type: Paper in international publication Authors: Abreu, Delvys Rodriguez; Audigier-Valette, Clarisse; Badin, Firas Benyamine; Barlesi, Fabrice; Bennouna, Jaafar; Chisamore, Michael J; Erman, Mustafa; Felip, Enriqueta; Isla, Dolores; Kim, Hye Ryun et al. DOI: 10.1016/j.cllc.2018.12.022 Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice. PMID: 31351931 Journal: EBioMedicine Year: 2019 Reference: EBioMedicine. 2019 Aug;46:342-355. doi: 10.1016/j.ebiom.2019.07.042. Epub 2019 Jul 24. Impact factor: 6.68 Publication type: Paper in international publication Authors: Molina-Granada, David, Vila-Julia, Ferran, Jimenez-Heis, Daniel, Zhou, Xiaoshan, Torres-Torronteras, Javier, Karlsson, Anna, Marti, Ramon, Camara, Yolanda, Blazquez-Bermejo, Cora et al. DOI: 10.1016/j.ebiom.2019.07.042 Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice. PMID: 31351931 Journal: EBioMedicine Year: 2019 Reference: EBioMedicine. 2019 Aug;46:342-355. doi: 10.1016/j.ebiom.2019.07.042. Epub 2019 Jul 24. Impact factor: Publication type: Paper in international publication Authors: Blazquez-Bermejo, Cora; Camara, Yolanda; Jimenez-Heis, Daniel; Karlsson, Anna; Marti, Ramon; Molina-Granada, David; Torres-Torronteras, Javier; Vila-Julia, Ferran; Zhou, Xiaoshan et al. DOI: 10.1016/j.ebiom.2019.07.042 Agnostic-Histology Approval of new drugs in Oncology: are we already there? PMID: 30670489 Journal: CLINICAL CANCER RESEARCH Year: 2019 Reference: Clin Cancer Res. 2019 Jun 1;25(11):3210-3219. doi: 10.1158/1078-0432.CCR-18-3694. Epub 2019 Jan 22. Impact factor: 8.911 Publication type: Paper in international publication Authors: Hierro, Cinta, Matos, Ignacio, Martin-Liberal, Juan, Ochoa de Olza, Maria, Garralda, Elena et al. DOI: 10.1158/1078-0432.CCR-18-3694 Agnostic-Histology Approval of new drugs in Oncology: are we already there? PMID: 30670489 Journal: CLINICAL CANCER RESEARCH Year: 2019 Reference: Clin Cancer Res. 2019 Jun 1;25(11):3210-3219. doi: 10.1158/1078-0432.CCR-18-3694. Epub 2019 Jan 22. Impact factor: Publication type: Paper in international publication Authors: Garralda, Elena; Hierro, Cinta; Martin-Liberal, Juan; Matos, Ignacio; Ochoa de Olza, Maria et al. DOI: 10.1158/1078-0432.CCR-18-3694 Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases. PMID: 31639024 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Oct 21;14(1):230. doi: 10.1186/s13023-019-1202-6. Impact factor: 3.687 Publication type: Paper in international publication Authors: Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pardo-Mateos, Almudena, Malfettone, Andrea, Perez-Garcia, Jose, Llombart-Cussac, Antonio, Cortes, Javier, Molto-Abad, Marc, Munoz-Delgado, Cecilia, Perez-Quintana, Marta et al. DOI: 10.1186/s13023-019-1202-6 Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases. PMID: 31639024 Journal: Orphanet Journal of Rare Diseases Year: 2019 Reference: Orphanet J Rare Dis. 2019 Oct 21;14(1):230. doi: 10.1186/s13023-019-1202-6. Impact factor: Publication type: Paper in international publication Authors: Cortes, Javier; Llombart-Cussac, Antonio; Malfettone, Andrea; Miguel-Huguet, Bernat; Molto-Abad, Marc; Munoz-Delgado, Cecilia; Pardo-Mateos, Almudena; Perez-Garcia, Jose; Perez-Lopez, Jordi; Perez-Quintana, Marta et al. DOI: 10.1186/s13023-019-1202-6 Airway Alterations and Diffuse Alveolar Damage in Acute Respiratory Distress Syndrome: Is There Any Association? PMID: 29861071 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2019 Reference: Arch Bronconeumol. 2019 Jan;55(1):3-4. doi: 10.1016/j.arbres.2018.04.003. Epub 2018 May 31. Impact factor: 4.214 Publication type: Paper in national publication Authors: Griffiths, Mark J D, Soriano-Navarro, Tania, Garcia-de-Acilu, Marina, Roca, Oriol et al. DOI: 10.1016/j.arbres.2018.04.003 Airway Alterations and Diffuse Alveolar Damage in Acute Respiratory Distress Syndrome: Is There Any Association? PMID: 29861071 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2019 Reference: Arch Bronconeumol. 2019 Jan;55(1):3-4. doi: 10.1016/j.arbres.2018.04.003. Epub 2018 May 31. Impact factor: Publication type: Paper in national publication Authors: Garcia-de-Acilu, Marina; Griffiths, Mark J D; Roca, Oriol; Soriano-Navarro, Tania et al. DOI: 10.1016/j.arbres.2018.04.003 Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). PMID: 31053546 Journal: Annals of Hepatology Year: 2019 Reference: Ann Hepatol. 2019 May - Jun;18(3):518-535. doi: 10.1016/j.aohep.2019.04.005. Epub 2019 Apr 18. Impact factor: 1.895 Publication type: Paper in international publication Authors: Abraldes, Juan G, Arab, Juan P, Roblero, Juan P, Altamirano, Jose, Bessone, Fernando, Chaves Araujo, Roberta, Higuera-De la Tijera, Fatima, Restrepo, Juan Carlos, Torre, Aldo, Urzua, Alvaro et al. DOI: 10.1016/j.aohep.2019.04.005 Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). PMID: 31053546 Journal: Annals of Hepatology Year: 2019 Reference: Ann Hepatol. 2019 May - Jun;18(3):518-535. doi: 10.1016/j.aohep.2019.04.005. Epub 2019 Apr 18. Impact factor: Publication type: Paper in international publication Authors: Abraldes, Juan G; Altamirano, Jose; Arab, Juan P; Bataller, Ramon; Bessone, Fernando; Chaves Araujo, Roberta; Contreras, Fernando; Cortez-Pinto, Helena; Higuera-De la Tijera, Fatima; Lucey, Michael R et al. DOI: 10.1016/j.aohep.2019.04.005 Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. PMID: 31771785 Journal: Gastroenterologia y Hepatologia Year: 2019 Reference: Gastroenterol Hepatol. 2019 Dec;42(10):657-676. doi: 10.1016/j.gastrohep.2019.09.006. Epub 2019 Nov 23. Impact factor: 1.126 Publication type: Paper in national publication Authors: Bataller, Ramon, Cabezas, Joaquin, Aller, Rocio, Ventura-Cots, Meritxell, Abad, Javier, Albillos, Agustin, Altamirano, Jose, Arias-Loste, Maria Teresa, Banares, Rafael, Caballeria, Juan et al. DOI: 10.1016/j.gastrohep.2019.09.006 Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. PMID: 31771785 Journal: Gastroenterologia y Hepatologia Year: 2019 Reference: Gastroenterol Hepatol. 2019 Dec;42(10):657-676. doi: 10.1016/j.gastrohep.2019.09.006. Epub 2019 Nov 23. Impact factor: Publication type: Paper in national publication Authors: Abad, Javier; Albillos, Agustin; Aller, Rocio; Altamirano, Jose; Arias-Loste, Maria Teresa; Banares, Rafael; Bataller, Ramon; Caballeria, Juan; Caballeria, Llorenc; Cabezas, Joaquin et al. DOI: 10.1016/j.gastrohep.2019.09.006 ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer. PMID: 30892989 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2019 Reference: J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20. Impact factor: 28.245 Publication type: Paper in international publication Authors: Shaw, Alice T, Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Lin, Chia-Chi, Soo, Ross A, Riely, Gregory J, Ou, Sai-Hong Ignatius, Clancy, Jill S, Li, Sherry et al. DOI: 10.1200/JCO.18.02236 ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer. PMID: 30892989 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2019 Reference: J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20. Impact factor: Publication type: Paper in international publication Authors: Abbattista, Antonello; Bauer, Todd M; Besse, Benjamin; Camidge, D Ross; Chiari, Rita; Clancy, Jill S; Felip, Enriqueta; Gadgeel, Shirish M; Kao, Steven; Li, Sherry et al. DOI: 10.1200/JCO.18.02236 Pagination First page « First Previous page ‹ Previous … Page 661 Page 662 Page 663 Page 664 Current page 665 Page 666 Page 667 Page 668 Page 669 … Next page Next › Last page Last »
